Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Open Label, Single Arm, First in Human (FIH) Clinical Study to Assess Safety and Efficacy of the CorNeat Keratoprosthesis for the Treatment of Corneal Blindness

NCT04485858 is registered in ClinicalTrials.gov with CorNeat Vision Ltd. as lead sponsor.

NCT NCT04485858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04485858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Open Label, Single Arm, First in Human (FIH) Clinical Study to Assess Safety and Efficacy of the CorNeat Keratoprosthesis for the Treatment of Corneal Blindness
Lead sponsor
CorNeat Vision Ltd.
Phase
Not applicable
Overall status
Terminated
Start date
January 3, 2021
Completion date
June 1, 2023
Enrollment
10 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

corneal disease, corneal injuries, corneal opacity